1. Home
  2. Analysis
  3. Victoza
  4. Faslodex

Victoza and Faslodex drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Victoza (liraglutide) and Faslodex (fulvestrant). Common drug interactions include diarrhoea among females.

The phase IV clinical study analyzes what interactions people have when they take Victoza and Faslodex. It is created by eHealthMe based on reports of 12 people who take the same drugs from the FDA, and is updated regularly.

What is Victoza?

Victoza has active ingredients of liraglutide. It is often used in diabetes. eHealthMe is studying from 42,880 Victoza users. Check the latest studies of Victoza.

What is Faslodex?

Faslodex has active ingredients of fulvestrant. It is often used in breast cancer metastatic. eHealthMe is studying from 19,255 Faslodex users. Check the latest studies of Faslodex.

On Jul, 09, 2026

12 people who take Victoza and Faslodex together, and have interactions are studied.

Victoza and Faslodex drug interactions.

What are the common drug interactions of Victoza and Faslodex, by gender? *:

female:

  1. Diarrhoea
  2. Asthenia (weakness)
  3. White blood cell count decreased
  4. Arteriosclerosis (thickening and hardening of arteries)
  5. Arteriosclerosis coronary artery (thickening and hardening of arteries- coronary artery)
  6. Balance disorder
  7. Blood iron decreased
  8. Cough
  9. Drug ineffective
  10. Dysstasia (difficulty in standing)

male:

n/a

What are the common drug interactions of Victoza and Faslodex, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Asthenia (weakness)
  2. Blood iron decreased
  3. Decreased appetite
  4. Dyspnoea (difficult or laboured respiration)
  5. Fatigue (feeling of tiredness)
  6. Haemoglobin decreased
  7. Palpitations (feelings or sensations that your heart is pounding or racing)
  8. Red blood cell count increased
  9. White blood cell count decreased

50-59:

n/a

60+:

  1. Diarrhoea
  2. Arthralgia (joint pain)
  3. Arteriosclerosis coronary artery (thickening and hardening of arteries- coronary artery)
  4. Balance disorder
  5. Cough
  6. Drug ineffective
  7. Dyspnoea (difficult or laboured respiration)
  8. Dysstasia (difficulty in standing)
  9. Gingival disorder (gum disease)
  10. Hypoaesthesia (reduced sense of touch or sensation)

What are the existing conditions these people have? *

  1. Breast Cancer Female: 3 people, 25.00%
  2. Oestrogen Receptor Assay Positive: 1 person, 8.33%
  3. Metastases To Bone (cancer spreads to bone): 1 person, 8.33%
  4. Diarrhea: 1 person, 8.33%
  5. Breast Cancer: 1 person, 8.33%
  6. Bone Neoplasm (tumour of bone): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Victoza and Faslodex?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Victoza and Faslodex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Victoza:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Faslodex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Victoza and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Faslodex and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies

How the study uses the data?

The study uses data from the FDA. It is based on liraglutide and fulvestrant (the active ingredients of Victoza and Faslodex, respectively), and Victoza and Faslodex (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.